evolocumab
amgen
['evolocumab', 'fourier', 'cardio']
fourier-ole studies: in pts w/ stable ascvd, long-term use of evolocumab with median follow-up of more than 7 yrs appears safe and well-tolerated. cardiovascular benefit shown by lower incidence of adverse events. #esccongress #esc22 
Non-Profit Founder/Leader | ?? Doc | Artist | Scientist | Educator | News Anchor https://t.co/usmuA3tKft | RT ? endorse | Disclaimer: https://t.co/bwmE2O3U5W